MECHANISMS OF RESISTANCE TO TOPOISOMERASES POISONS

Authors
Citation
S. Prost, MECHANISMS OF RESISTANCE TO TOPOISOMERASES POISONS, General pharmacology, 26(8), 1995, pp. 1773-1784
Citations number
88
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
03063623
Volume
26
Issue
8
Year of publication
1995
Pages
1773 - 1784
Database
ISI
SICI code
0306-3623(1995)26:8<1773:MORTTP>2.0.ZU;2-W
Abstract
1. Drug resistance remains a major obstacle to cancer treatment. Resis tance to chemotherapy can be intrinsic, characterised by the nonrespon siveness of the tumour to the initial treatment. Alternatively, cancer s that initially respond to chemotherapy can relapse after various tim es because of acquired resistance. 2. Resistance to drugs used as sing le agents is generally accompanied by the development of resistance to other drugs that can be structurally and functionally different. 3. A mong the drugs commonly used in cancer treatment there are compounds t hat have been shown to inhibit DNA topoisomerases (Topos). These criti cal enzymes regulate the topological conformation of the DNA and parti cipate in essential cellular processes. 4. This paper reviews the Topo s' cellular functions, their catalytic activities and the mechanisms o f resistance to inhibitors of Topos, with particular attention to the atypical multidrug resistance phenotype.